newsfilter
← Latest News
GlobeNewswire·

Decibel Therapeutics Appoints Matthew Kapusta to its Board of Directors

BOSTON, March 21, 2023 (GLOBE NEWSWIRE) -- Decibel Therapeutics (NASDAQ:DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore and improve hearing and